Image of buildings with lights at night
Welcome AASLD 2022!
HelioLiver is proud to welcome our friends here in Washington, D.C.
Logo of AASLD
Logo of AASLD
Visit Us at Booth #709
Stop by to chat with a HelioLiver rep and learn about our early liver cancer test!
image helio booth location
Introducing HelioLiver™: A New Liver Cancer Detection Test

HelioLiver is a multi-analyte blood test that incorporates cell-free DNA (cfDNA) methylation patterns, clinical variables, serum protein markers, and demographic information for the (early) detection of hepatocellular carcinoma (HCC), the most common form of liver cancer.

With just one blood draw, HelioLiver offers a combination of ease and convenience to at-risk patients for liver cancer surveillance testing.

Helio liver collection kit
Clinical Confidence Backed by Data
By combining the results of cell-free DNA methylation analysis with data from protein tumor markers and other clinical information, the HelioLiver test delivers superior performance characteristics when compared to traditional blood tests for hepatocellular carcinoma (HCC).
Early Stage (I+II)
Sensitivity
Specificity
HelioLiver™
clinical data
91%
AFP
(≥ 20 ng/mL)
clinical data
97%
GALAD
(Gender, Age,
AFP-L3%, AFP, DCP)
clinical data
94%
All Stages
Sensitivity
Specificity
HelioLiver™
clinical data
91%
AFP
(≥ 20 ng/mL)
clinical data
97%
GALAD
(Gender, Age,
AFP-L3%, AFP, DCP)
clinical data
94%
How it Works
Ordering the HelioLiver test is simple and straightforward
Order Test

Providers can directly
order tests online or by
paper TRF

Collect Sample

Use the materials in our
test kit for a single blood
draw

Ship it back

A return shipping label
included in our test kit

Wait for Analysis

Our average turnaround
time is 7-10 days for complete
analysis

Get your report

Uploaded directly to our
provider portal for easy
access

Patient-Friendly Results
A one-page report indicates either abnormal or normal findings, allowing providers to quickly determine the next step of care
Abnormal
What does it Mean?
May indicate HCC was detected in the sample
What's the next step?

Follow provider guidelines to follow up with additional
diagnostic imaging

Normal
What does it Mean?
Indicates a low likelihood of HCC in the sample
What's the next step?

Continued surveillance every 3-6 months, depending on
provider guidance

Subscribe for product updates and upcoming webinars

* indicates required